Fifty-year follow-up and Strampelli anterior chamber intraocular lens
The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothel...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
German Medical Science GMS Publishing House
2015-09-01
|
Series: | GMS Ophthalmology Cases |
Online Access: | http://www.egms.de/static/en/journals/oc/2015-5/oc000028.shtml |
id |
doaj-55096b0cfd304d3eba1e8837a3cf6d2c |
---|---|
record_format |
Article |
spelling |
doaj-55096b0cfd304d3eba1e8837a3cf6d2c2020-11-25T03:20:41ZengGerman Medical Science GMS Publishing HouseGMS Ophthalmology Cases2193-14962015-09-015Doc0610.3205/oc000028Fifty-year follow-up and Strampelli anterior chamber intraocular lensOakley, Carmen L.0Nigro, Matthew A.1Vote, Brendan J.2Tasmanian Eye Institute, Launceston, Tasmania, AustraliaTasmanian Eye Institute, Launceston, Tasmania, AustraliaTasmanian Eye Institute, Launceston, Tasmania, AustraliaThe Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.http://www.egms.de/static/en/journals/oc/2015-5/oc000028.shtml |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Oakley, Carmen L. Nigro, Matthew A. Vote, Brendan J. |
spellingShingle |
Oakley, Carmen L. Nigro, Matthew A. Vote, Brendan J. Fifty-year follow-up and Strampelli anterior chamber intraocular lens GMS Ophthalmology Cases |
author_facet |
Oakley, Carmen L. Nigro, Matthew A. Vote, Brendan J. |
author_sort |
Oakley, Carmen L. |
title |
Fifty-year follow-up and Strampelli anterior chamber intraocular lens |
title_short |
Fifty-year follow-up and Strampelli anterior chamber intraocular lens |
title_full |
Fifty-year follow-up and Strampelli anterior chamber intraocular lens |
title_fullStr |
Fifty-year follow-up and Strampelli anterior chamber intraocular lens |
title_full_unstemmed |
Fifty-year follow-up and Strampelli anterior chamber intraocular lens |
title_sort |
fifty-year follow-up and strampelli anterior chamber intraocular lens |
publisher |
German Medical Science GMS Publishing House |
series |
GMS Ophthalmology Cases |
issn |
2193-1496 |
publishDate |
2015-09-01 |
description |
The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era. |
url |
http://www.egms.de/static/en/journals/oc/2015-5/oc000028.shtml |
work_keys_str_mv |
AT oakleycarmenl fiftyyearfollowupandstrampellianteriorchamberintraocularlens AT nigromatthewa fiftyyearfollowupandstrampellianteriorchamberintraocularlens AT votebrendanj fiftyyearfollowupandstrampellianteriorchamberintraocularlens |
_version_ |
1724617237364473856 |